Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration.

ABSTRACT: Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in people aged over 65 years in developed countries. Vascular endothelial growth factor (VEGF) is a positive regulator of angiogenesis and its proven role in the pathological neovascularization in wet AMD has provided evidence for the use of anti-VEGF agents as potential therapies. In this study, we review the literature for the possible causes of failure after treatment with anti-VEGF agents and attempt to propose an algorithm of suggestive actions to increase the chances of successful management of such difficult cases.

SUBMITTER: Tranos P 

PROVIDER: S-EPMC3692343 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature